Dare Bioscience DARE
NASDAQ DARE
$0.65 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Dare Bioscience (DARE) Gross Profit (2025 - 2026)

Updated

Dare Bioscience (DARE) posted Gross Profit of -$132,343 for Q2 2026, compared with -$21,172 a year earlier.

Analysis

Dare Bioscience (DARE) Gross Profit (2025 - 2026) Analysis & Trends

For FY2025, Dare Bioscience's Gross Profit came in at $734,394.

  • In prior years, Dare Bioscience's Gross Profit was $9,784 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Dare Bioscience 9.86 Mn -55.60 Mn -132,343.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -132,343.00
Jun 30, 2025 -21,172.00
API Access

Dare Bioscience Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=DARE&period=max&api_key=YOUR_API_KEY